LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis
Authors
Keywords
-
Journal
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2023-10-30
DOI
10.1080/14737159.2023.2277521
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LncRNA Linc00173 may be a potential prognostic biomarker in human solid tumors: a meta—analysis and bioinformatics analysis
- (2023) Cong Zhou et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Lnc-AIFM2-1 promotes HBV immune escape by acting as a ceRNA for miR-330-3p to regulate CD244 expression
- (2023) Chengxia Xie et al. Frontiers in Immunology
- The EMT-induced lncRNA NR2F1-AS1 positively modulates NR2F1 expression and drives gastric cancer via miR-29a-3p/VAMP7 axis
- (2022) Dandan Li et al. Cell Death & Disease
- NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641
- (2022) Yan Zhong et al. Journal of Healthcare Engineering
- Hypoxia-induced long noncoding RNA NR2F1-AS1 maintains pancreatic cancer proliferation, migration, and invasion by activating the NR2F1/AKT/mTOR axis
- (2022) Yanqing Liu et al. Cell Death & Disease
- Long noncoding RNAs as promising biomarkers in cancer
- (2022) Ozal Beylerli et al. Non-coding RNA Research
- Biological role of long non-coding RNA FTX in cancer progression
- (2022) Jinlan Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis
- (2022) Sajad Najafi et al. EXPERIMENTAL CELL RESEARCH
- A review on the role of NR2F1-AS1 in the development of cancer
- (2022) Soudeh Ghafouri-Fard et al. PATHOLOGY RESEARCH AND PRACTICE
- The role of lncRNA CERS6-AS1 in cancer and its molecular mechanisms: A systematic review and meta-analysis
- (2022) Hadith Rastad et al. PATHOLOGY RESEARCH AND PRACTICE
- NR2F1-AS1/miR-140/HK2 Axis Regulates Hypoxia-Induced Glycolysis and Migration in Hepatocellular Carcinoma
- (2021) Xiao Li et al. Cancer Management and Research
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- STAT3 activates the transcription of lncRNA NR2F1‐AS1 to promote the progression of melanoma via regulating the miR‐493‐5p/GOLM1 axis
- (2021) Mei Bai et al. JOURNAL OF GENE MEDICINE
- The Effect and Mechanism of lncRNA NR2F1-As1/miR-493-5p/MAP3K2 Axis in the Progression of Gastric Cancer
- (2021) Xiaobin Liao et al. Journal of Oncology
- Long Noncoding RNA NR2F1-AS1 Enhances the Migration and Invasion of Hepatocellular Carcinoma via Modulating miR-642a/DEK Pathway
- (2021) Yingxia Xu et al. Journal of Oncology
- Long noncoding RNA NR2F1-AS1 stimulates the tumorigenic behavior of non-small cell lung cancer cells by sponging miR-363-3p to increase SOX4
- (2021) Luming Jin et al. Open Medicine
- NR2F1-AS1/miR-190a/PHLDB2 Induces the Epithelial–Mesenchymal Transformation Process in Gastric Cancer by Promoting Phosphorylation of AKT3
- (2021) Jinqi Lv et al. Frontiers in Cell and Developmental Biology
- Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis
- (2020) Si Zhao et al. BMC CANCER
- Long noncoding RNA NR2F1-AS1 promotes the malignancy of non-small cell lung cancer via sponging microRNA-493-5p and thereby increasing ITGB1 expression
- (2020) Chan Zhang et al. Aging-US
- lncRNA NR2F1‐AS1 promotes breast cancer angiogenesis through activating IGF‐1/IGF‐1R/ERK pathway
- (2020) Qi Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Principles and innovative technologies for decrypting noncoding RNAs: from discovery and functional prediction to clinical application
- (2020) Yu-Meng Sun et al. Journal of Hematology & Oncology
- Long non‑coding RNA NR2F1‑AS1 facilitates the osteosarcoma cell malignant phenotype via the miR‑485‑5p/miR‑218‑5p/BIRC5 axis
- (2020) Guanghui Jia et al. ONCOLOGY REPORTS
- Challenges and Strategies in Ascribing Functions to Long Noncoding RNAs
- (2020) Yang Zhao et al. Cancers
- Long non‐coding RNA NR2F1‐AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA‐338‐3p/ CCND1 axis
- (2019) Feng Guo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- NR2F1-induced NR2F1-AS1 promotes esophageal squamous cell carcinoma progression via activating Hedgehog signaling pathway
- (2019) Yaowen Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Role of Non-coding RNAs in Oncology
- (2019) Frank J. Slack et al. CELL
- NR2F1‐AS1 regulated miR‐423‐5p/SOX12 to promote proliferation and invasion of papillary thyroid carcinoma
- (2019) Chuanjia Yang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Long noncoding RNA NR2F1-AS1 enhances the malignant properties of osteosarcoma by increasing forkhead box A1 expression via sponging of microRNA-483-3p
- (2019) Shenglong Li et al. Aging-US
- Direct detection of early-stage cancers using circulating tumor DNA
- (2017) Jillian Phallen et al. Science Translational Medicine
- Long-term Toxicity of Cancer Treatment in Older Patients
- (2016) Armin Shahrokni et al. CLINICS IN GERIATRIC MEDICINE
- Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets
- (2016) Subash Chandra Gupta et al. INTERNATIONAL JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started